Global Bio-chem Technology Group Company Limited
0809.HK · HKSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 0.01 | -0.00 |
| FCF Yield | 6.28% | 1.43% | -1.09% | 0.24% |
| EV / EBITDA | 74.69 | 95.16 | 45.23 | 1.47 |
| Quality | ||||
| ROIC | 1.88% | -0.15% | -7.41% | -6.11% |
| Gross Margin | 13.59% | 13.85% | 7.35% | 11.51% |
| Cash Conversion Ratio | -0.35 | 0.01 | 0.06 | 0.01 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.48% | -14.55% | -31.56% | -44.51% |
| Free Cash Flow Growth | 274.93% | 255.72% | -484.77% | 101.51% |
| Safety | ||||
| Net Debt / EBITDA | 60.50 | 75.38 | 37.37 | 1.25 |
| Interest Coverage | 0.14 | -0.01 | -0.72 | -0.23 |
| Efficiency | ||||
| Inventory Turnover | 3.74 | 4.62 | 2.76 | 4.24 |
| Cash Conversion Cycle | -99.45 | 48.74 | -46.50 | -57.96 |